These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 36855960)

  • 61. Outcomes in Newly Diagnosed Atrial Fibrillation and History of Acute Coronary Syndromes: Insights from GARFIELD-AF.
    Verheugt FWA; Ambrosio G; Atar D; Bassand JP; Camm AJ; Costabel JP; Fitzmaurice DA; Illingworth L; Goldhaber SZ; Goto S; Haas S; Jansky P; Kayani G; Stepinska J; Turpie AGG; van Eickels M; Kakkar AK;
    Am J Med; 2019 Dec; 132(12):1431-1440.e7. PubMed ID: 31306621
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Echocardiography in newly diagnosed atrial fibrillation patients: a systematic review and economic evaluation.
    Simpson E; Stevenson M; Scope A; Poku E; Minton J; Evans P
    Health Technol Assess; 2013 Aug; 17(36):1-263, v-vi. PubMed ID: 23985296
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Left atrial enlargement is an independent predictor of stroke and systemic embolism in patients with non-valvular atrial fibrillation.
    Hamatani Y; Ogawa H; Takabayashi K; Yamashita Y; Takagi D; Esato M; Chun YH; Tsuji H; Wada H; Hasegawa K; Abe M; Lip GY; Akao M
    Sci Rep; 2016 Aug; 6():31042. PubMed ID: 27485817
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Performance of the ABC Scores for Assessing the Risk of Stroke or Systemic Embolism and Bleeding in Patients With Atrial Fibrillation in ENGAGE AF-TIMI 48.
    Berg DD; Ruff CT; Jarolim P; Giugliano RP; Nordio F; Lanz HJ; Mercuri MF; Antman EM; Braunwald E; Morrow DA
    Circulation; 2019 Feb; 139(6):760-771. PubMed ID: 30586727
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Stroke and bleeding risk scores in patients with atrial fibrillation and valvular heart disease: evaluating 'valvular heart disease' in a nationwide cohort study.
    Lip GYH; Jensen M; Melgaard L; Skjøth F; Nielsen PB; Larsen TB
    Europace; 2019 Jan; 21(1):33-40. PubMed ID: 29986001
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Association of Race and Ethnicity With Oral Anticoagulation and Associated Outcomes in Patients With Atrial Fibrillation: Findings From the Get With The Guidelines-Atrial Fibrillation Registry.
    Essien UR; Chiswell K; Kaltenbach LA; Wang TY; Fonarow GC; Thomas KL; Turakhia MP; Benjamin EJ; Rodriguez F; Fang MC; Magnani JW; Yancy CW; Piccini JP
    JAMA Cardiol; 2022 Dec; 7(12):1207-1217. PubMed ID: 36287545
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Increased risk of ischemic stroke and systemic embolism in hyperthyroidism-related atrial fibrillation: A nationwide cohort study.
    Kim K; Yang PS; Jang E; Yu HT; Kim TH; Uhm JS; Kim JY; Sung JH; Pak HN; Lee MH; Lip GYH; Joung B
    Am Heart J; 2021 Dec; 242():123-131. PubMed ID: 34480879
    [TBL] [Abstract][Full Text] [Related]  

  • 68. One-year risks of stroke and mortality in patients with atrial fibrillation from different clinical settings: The Gulf SAFE registry and Darlington AF registry.
    Li YG; Miyazawa K; Wolff A; Zubaid M; Alsheikh-Ali AA; Sulaiman K; Lip GYH
    Int J Cardiol; 2019 Jan; 274():158-162. PubMed ID: 30291008
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Risk Levels and Adverse Clinical Outcomes Among Patients With Nonvalvular Atrial Fibrillation Receiving Oral Anticoagulants.
    Lip GYH; Murphy RR; Sahiar F; Ingall TJ; Dhamane AD; Ferri M; Hlavacek P; Preib MT; Keshishian A; Russ C; Rosenblatt L; Yuce H; Deitelzweig S
    JAMA Netw Open; 2022 Aug; 5(8):e2229333. PubMed ID: 36044214
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.
    Jacobs V; May HT; Bair TL; Crandall BG; Cutler M; Day JD; Weiss JP; Osborn JS; Muhlestein JB; Anderson JL; Mallender C; Bunch TJ
    Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Incidence and outcomes of patients with atrial fibrillation and major bleeding complications: from the TREAT-AF study.
    Perino AC; Kaiser DW; Lee RJ; Fan J; Askari M; Schmitt SK; Turakhia MP
    J Interv Card Electrophysiol; 2021 Oct; 62(1):133-142. PubMed ID: 32986177
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Predictors for Stroke and Death in Non-Anticoagulated Asian Patients with Atrial Fibrillation: The Fushimi AF Registry.
    Hamatani Y; Yamashita Y; Esato M; Chun YH; Tsuji H; Wada H; Hasegawa K; Abe M; Lip GY; Akao M
    PLoS One; 2015; 10(11):e0142394. PubMed ID: 26540107
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Oral Anticoagulation and the Risk of Stroke or Death in Patients With Atrial Fibrillation and One Additional Stroke Risk Factor: The Loire Valley Atrial Fibrillation Project.
    Fauchier L; Lecoq C; Clementy N; Bernard A; Angoulvant D; Ivanes F; Babuty D; Lip GY
    Chest; 2016 Apr; 149(4):960-8. PubMed ID: 26425935
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Characteristics and antithrombotic treatment patterns of patients with concomitant coronary artery disease and atrial fibrillation from Thailand's COOL-AF registry.
    Winijkul A; Kaewkumdee P; Yindeengam A; Krittayaphong R
    BMC Cardiovasc Disord; 2021 Mar; 21(1):117. PubMed ID: 33653277
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Frequency of cardioversions as an additional risk factor for stroke in atrial fibrillation - the FinCV-4 study.
    Jaakkola S; Kiviniemi TO; Jaakkola J; Pouru JP; Nuotio I; Vasankari T; Hartikainen JEK; Airaksinen KEJ
    Ann Med; 2022 Dec; 54(1):1452-1458. PubMed ID: 35594342
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Comparative Performance of ATRIA, CHADS2, and CHA2DS2-VASc Risk Scores Predicting Stroke in Patients With Atrial Fibrillation: Results From a National Primary Care Database.
    van den Ham HA; Klungel OH; Singer DE; Leufkens HG; van Staa TP
    J Am Coll Cardiol; 2015 Oct; 66(17):1851-9. PubMed ID: 26493655
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Optimising stroke prevention in patients with atrial fibrillation: application of the GRASP-AF audit tool in a UK general practice cohort.
    Shantsila E; Wolff A; Lip GY; Lane DA
    Br J Gen Pract; 2015 Jan; 65(630):e16-23. PubMed ID: 25548312
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-VASc score (beyond sex) receive oral anticoagulation?
    Chao TF; Liu CJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chen TJ; Lip GY; Chen SA
    J Am Coll Cardiol; 2015 Feb; 65(7):635-42. PubMed ID: 25677422
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation.
    Tu HT; Campbell BC; Meretoja A; Churilov L; Lees KR; Donnan GA; Davis SM
    Cerebrovasc Dis; 2013; 36(4):273-80. PubMed ID: 24135809
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Practice Variation in Anticoagulation Prescription and Outcomes After Device-Detected Atrial Fibrillation.
    Perino AC; Fan J; Askari M; Heidenreich PA; Keung E; Raitt MH; Piccini JP; Ziegler PD; Turakhia MP
    Circulation; 2019 May; 139(22):2502-2512. PubMed ID: 30880434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.